China Stocks Underpinned By Gradual Credit Easing

Gene Linn |

china life insuranceChina stocks ended a wild week little changed after swinging up and down according to breaking news on the European debt drama. But behind the volatility, China’s gradual move to loosen tight credit controls gave stocks a small but significant push forward.

On Friday, fears faded that a Greek referendum would scuttle Europe’s plan to deal with its debt problem, and the European Central Bank announced a surprise rate cut. The result was a 3.1% surge in Hong Kong’s Hang Seng Index to 19,843. The Index ended the week with a slight 0.9% loss. The index of Chinese companies rose 0.8% to 10,705.

News from China has buoyed the market recently. Chinese authorities announced last week they would begin “fine tuning” to ease inflation-fighting tight credit policies. Then this week China’s “big four” banks eased lending requirements.

A-share stocks on Chinese markets rose as a result, according to Ben Kwong, chief operating officer at KGI Asia. This triggered a strong rebound in insurance companies, he told Equities in an email. The banking sector and fixed asset investment plays also moved up on the news of loan easing.



“We believe that the relaxation of bank loan would favor those fixed asset investment plays like cement, construction equipment,” Kwong said. “Although several of them already accumulated sizable gain, [investors] could still buy during correction as fund flow will still favor those counters in the near term.” End

DAILY FIX

Hong Kong Blue Chips: +600, +3.1%, to 19,843, 11-04-11, Hang Seng Index

Chinese Stocks in Hong Kong: +411, +4.0% to 10,705, 11-04-11, HSCE Index

Shanghai Stocks: +0.8%, 2,528 11-04-11, Shanghai Composite Index.

Chinese Stocks in the U.S.: +2.0, to 392.9, 11-3-11, Bank of New York Mellon, ADR Index-China

Insight: News of a European interest rate cut and the decision by Greek leaders not to put the Europe debt solution plan to a vote triggered a sharp rise in the Hong Kong market. Chinese insurance companies surged: China Life (LFC) rose 7.3%. Speculation China would allow oil refiners to set their own prices boosted Petrochina (PTR) 8.3% higher. KGI Research

Quotable: "Its (the Hang Seng Index) initial resistance is seen at 19,745 (rebound peak at Wednesday), while second resistance is at 100 Day SMA (20,276). First and second support will be seen at 50 Day SMA(18,896) and 18,500." KGI Asia. 11-4-11

Chinese Company to Watch: Zhuzhou CSR Times Electric "Being the only train-borne electrical system manufacturer of CSR group, Zhuzhou CSR Times Electric holds a prominent position in the industry, possessing seven core technologies and excellent independent R&D capabilities, which in turn make it a leading supplier of rail transport electrical systems in China." Haitong Securities. 11-4-11

Brokerages and analysts cited have disclaimers on their websites emphasizing their statements are for information only. They do not endorse my blog, and I don't endorse them.
For a list of Chinese companies sold in the U.S. and information on each company go to http://www.adrbnymellon.com/dr_country_profile.jsp?country=CN

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
SBS:CA SemBioSys Genetics Inc. n/a n/a n/a 0
PTR PetroChina Company Limited 70.34 -0.12 -0.17 35,068 Trade
LFC China Life Insurance Company Limited American Depo 15.21 0.08 0.50 103,615 Trade

Comments

Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…